论文部分内容阅读
我们在细胞培养中和动物体内确定了病毒唑有抗汉坦病毒作用后,又采用双盲随机对照研究,观察了病毒唑在流行性出血热(EHF)患者体内的抗病毒作用,结果如下。
We determined the anti-Hantavirus effect of ribavirin in cell culture and in animals, followed by a double-blind, randomized, controlled study of the antiviral effect of ribavirin in patients with epidemic hemorrhagic fever (EHF). The results are as follows.